share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON KIMBERLY H

SEC announcement ·  Jun 19 04:24
Summary by Futu AI
On June 17, 2024, Kimberly H. Johnson, associated with Eli Lilly and Co (LLY), completed a purchase transaction of the company's common stock. The transaction involved the acquisition of 11 shares at a price of $885.01 per share. Following this transaction, Johnson's direct holdings in Eli Lilly and Co increased to a total of 2,654 shares. The transaction, which was conducted in USD, is classified as a grant, award, or other acquisition, according to the transaction code description provided.
On June 17, 2024, Kimberly H. Johnson, associated with Eli Lilly and Co (LLY), completed a purchase transaction of the company's common stock. The transaction involved the acquisition of 11 shares at a price of $885.01 per share. Following this transaction, Johnson's direct holdings in Eli Lilly and Co increased to a total of 2,654 shares. The transaction, which was conducted in USD, is classified as a grant, award, or other acquisition, according to the transaction code description provided.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.